 Arrowhead Pharmaceuticals Inc NASDAQ:ARWR Director Backer Marianne De bought 500 shares of the stock in a transaction on Monday, January 13th. The stock was purchased at an average price of 54.95 per share, with a total value of 27,475.00. Following the completion of the acquisition, the director now directly owns 13,000 shares in the company, ... 